Mafei Xu

454 total citations
12 papers, 241 citations indexed

About

Mafei Xu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Mafei Xu has authored 12 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Mafei Xu's work include Nuclear Receptors and Signaling (3 papers), Estrogen and related hormone effects (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Mafei Xu is often cited by papers focused on Nuclear Receptors and Signaling (3 papers), Estrogen and related hormone effects (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Mafei Xu collaborates with scholars based in China, United States and United Kingdom. Mafei Xu's co-authors include Sophia Y. Tsai, Ming‐Jer Tsai, Jun Qin, Hui-Ju Lee, Shih‐Chieh Lin, Leiming Wang, Xin Xie, Mujun Zhao, Tsaiping Li and Hugo J. Bellen and has published in prestigious journals such as Journal of Clinical Investigation, Oncogene and Scientific Reports.

In The Last Decade

Mafei Xu

12 papers receiving 240 citations

Peers

Mafei Xu

MB

CR

PHYSI

GENET

ONCOL

Mariaelena Pistoni Italy

Jill Schoenfeld United States

Guoliang Lyu China

Miriam Ferrer United States

Alessio Butera Italy

Rubén Fernández Spain

Yaiza Núñez‐Álvarez Spain

Xinyi Cao China

Lu Tian China

Jarrod P. Skinner Australia

Mariaelena Pistoni Italy

Mafei Xu

240 ×1.4

MB

62 ×1.0

CR

19 ×0.5

PHYSI

32 ×0.9

GENET

29 ×1.0

ONCOL

Citations per year, relative to Mafei Xu Mafei Xu (= 1×) peers Mariaelena Pistoni

Countries citing papers authored by Mafei Xu

Since Specialization

Citations

This map shows the geographic impact of Mafei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mafei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mafei Xu more than expected).

Fields of papers citing papers by Mafei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mafei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mafei Xu. The network helps show where Mafei Xu may publish in the future.

Co-authorship network of co-authors of Mafei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mafei Xu. A scholar is included among the top collaborators of Mafei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mafei Xu. Mafei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Lee, Hui-Ju, et al.. (2024). GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity. Oncogene. 43(34). 2595–2610. 3 indexed citations

2.

Ren, Xiaohe, et al.. (2024). A Multiple Targeting Genome Editing System for Remodulation of Circulating Malignant Cells to Eliminate Cancer Immunosuppression and Restore Immune Responses. Advanced Healthcare Materials. 14(1). e2401223–e2401223. 1 indexed citations

3.

Qin, Jun, Mafei Xu, Jingjing Shi, et al.. (2020). Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment. Science Advances. 6(18). eaaz8031–eaaz8031. 23 indexed citations

4.

Xu, Mafei, Shih‐Chieh Lin, Hui-Ju Lee, et al.. (2020). Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction. PLoS Genetics. 16(6). e1008868–e1008868. 16 indexed citations

5.

Xu, Mafei, Jun Qin, Dan Liu, et al.. (2019). Nuclear receptors regulate alternative lengthening of telomeres through a novel noncanonical FANCD2 pathway. Science Advances. 5(10). eaax6366–eaax6366. 22 indexed citations

6.

Wang, Leiming, et al.. (2019). Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1. Journal of Clinical Investigation. 130(4). 1782–1792. 52 indexed citations

7.

Lee, Hui-Ju, Shih‐Chieh Lin, Mafei Xu, et al.. (2017). Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. Scientific Reports. 7(1). 3136–3136. 21 indexed citations

8.

Xu, Mafei, Jun Qin, Shih‐Chieh Lin, et al.. (2016). MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer. Oncotarget. 7(12). 14673–14683. 52 indexed citations

9.

Xu, Mafei, Jun Qin, Sophia Y. Tsai, & Ming‐Jer Tsai. (2014). The role of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta Pharmacologica Sinica. 36(1). 32–36. 34 indexed citations

10.

Xu, Mafei, et al.. (2012). Microspherule protein 2 associates with ASK1 and acts as a negative regulator of stress‐induced ASK1 activation. FEBS Letters. 586(12). 1678–1686. 4 indexed citations

11.

Chen, Guoyuan, Liang Da, Ying Xu, et al.. (2010). C-terminal amino acids 290–328 of LPTS/PinX1 confer telomerase inhibition. Biochemical and Biophysical Research Communications. 398(4). 683–689. 8 indexed citations

12.

Xu, Mafei, Zhen Xing, Zhili Wu, et al.. (2009). Expression and function on embryonic development of lissencephaly-1 genes in zebrafish. Acta Biochimica et Biophysica Sinica. 41(8). 677–688. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact